» Articles » PMID: 25992377

Elucidating New Drug Targets in Psoriasis by Gene Profiling: an Opportunity to Be Seized

Overview
Journal Ann Transl Med
Date 2015 May 21
PMID 25992377
Authors
Affiliations
Soon will be listed here.
References
1.
Boyman O, Hefti H, Conrad C, Nickoloff B, Suter M, Nestle F . Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med. 2004; 199(5):731-6. PMC: 2213300. DOI: 10.1084/jem.20031482. View

2.
Bissonnette R, Papp K, Maari C, Yao Y, Robbie G, White W . A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis. J Am Acad Dermatol. 2010; 62(3):427-36. DOI: 10.1016/j.jaad.2009.05.042. View

3.
Lowes M, Suarez-Farinas M, Krueger J . Immunology of psoriasis. Annu Rev Immunol. 2014; 32:227-55. PMC: 4229247. DOI: 10.1146/annurev-immunol-032713-120225. View

4.
Noda S, Krueger J, Guttman-Yassky E . The translational revolution and use of biologics in patients with inflammatory skin diseases. J Allergy Clin Immunol. 2014; 135(2):324-36. DOI: 10.1016/j.jaci.2014.11.015. View

5.
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R . IL-22 increases the innate immunity of tissues. Immunity. 2004; 21(2):241-54. DOI: 10.1016/j.immuni.2004.07.007. View